Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ymk Holdings LLC maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The current prosecution landscape is defined by 1 pending office action. The examiner HAGHIGHATIAN, MINA is identified as the busiest examiner for the portfolio with 1 pending office action currently assigned. This indicates a concentrated focus for the company's current intellectual property efforts.
The administrative footprint of the portfolio involves 1 distinct examiner and 1 distinct art unit. This alignment between the 1 distinct examiner and 1 distinct art unit indicates a specific prosecution path within a technical domain. Because the 1 pending office action accounts for the company's current USPTO engagement, the outcome of this matter will impact the immediate growth of the portfolio. The 1 distinct art unit reflects a targeted approach to securing patent rights in this field. Practitioners should monitor this matter to gauge the company's success.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGHIGHATIAN, MINA | 1 | 46.0% | +39.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18864476 | METHOD FOR PRODUCING HYPOCHLOROUS ACID | HAGHIGHATIAN, MINA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18864476 | METHOD FOR PRODUCING HYPOCHLOROUS ACID | HAGHIGHATIAN, MINA | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18864476 | METHOD FOR PRODUCING HYPOCHLOROUS ACID | HAGHIGHATIAN, MINA | 1615 | §103§112 | Non-Final OA | — | Pending | Nov 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialYmk Holdings LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Mina Haghighatian has the most, with 1 of Ymk Holdings LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
